AI Article Synopsis
- Calciphylaxis is a rare and serious condition mainly seen in patients with advanced kidney disease or those who have undergone a kidney transplant.
- Nonuremic calciphylaxis causes tissue death due to insufficient blood flow, and is linked to various health issues such as hyperparathyroidism and certain cancers.
- Early diagnosis and a strong teamwork approach in treatment are crucial for improving survival rates.
Article Abstract
Calciphylaxis is a rare disease that typically presents in patients with end-stage renal disease on dialysis or those who have received a renal transplant. Nonuremic calciphylaxis leads to ischemia and subsequent necrosis of subcutaneous tissue. Diseases associated with nonuremic calciphylaxis include primary hyperparathyroidism, connective tissue disease, malignancy, and alcoholic liver disease. Due to its high mortality, early identification and an aggressive multidisciplinary treatment approach is necessary to improve patient outcomes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/01.JAA.0000532115.75508.72 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Surgical Management of Penile Calciphylaxis Without Penectomy.
Cureus
September 2024
Urology, Touro University California, Stockton, USA.
Article Synopsis
- - Calciphylaxis is a serious condition characterized by the calcification of small blood vessels, leading to tissue damage and ulcers, often seen in individuals with end-stage renal disease but can also affect those without kidney issues.
- - Risk factors for calciphylaxis include diabetes, hyperparathyroidism, certain cancers, use of warfarin, liver disease, and autoimmune disorders, making it essential to recognize these factors for effective diagnosis and treatment.
- - A case study describes a 58-year-old man with end-stage renal disease who developed penile calciphylaxis, leading to rapid tissue necrosis; he chose conservative treatment over surgery, opting for local wound care and antibiotics instead.
Successful treatment of non-uremic calciphylaxis with combination therapy with sodium thiosulfate, iloprost, and heparin.
Int J Dermatol
July 2024
Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Nonuremic Calciphylaxis: A Rare and Unexpected Diagnosis of Necrotic Ulcers.
J Am Podiatr Med Assoc
March 2024
‡Katherine Shaw Bethea Hospital, Dixon, IL.
Calciphylaxis is a rare and devastating condition found almost exclusively in patients with end-stage renal disease. Nonuremic calciphylaxis, an even more rare diagnosis, occurs in patients with preserved kidney function. We present a fatal case of nonuremic calciphylaxis with delayed and unexpected diagnosis despite early biopsy and testing.
View Article and Find Full Text PDFPrevalence and risk factors for development of recurrent calciphylaxis.
J Am Acad Dermatol
June 2024
Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address:
Clinical characteristics and treatment modalities in uremic and non uremic calciphylaxis - a dermatological single-center experience.
Ren Fail
December 2024
Hautklinik, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Calciphylaxis (CP) is a serious, potentially life-threatening disease that presents with medial calcification of small-sized vessels and painful ischemic ulcerations. Although calciphylaxis is frequently seen in patients with end-stage kidney disease on dialysis (calcific uremic arteriolopathy, CUA), there are reported cases of nonuremic calciphylaxis (NUC), which often remain undiagnosed. We conducted a retrospective chart review at our dermatological hospital and evaluated data concerning the epidemiology, comorbidities, medication, laboratory abnormalities, and therapeutic approaches of 60 patients diagnosed with calciphylaxis between 01/2012 and 12/2022.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!